Peptidylarginine deiminase type 2 is over expressed in the glaucomatous optic nerve

Molecular Vision

Volumn 16, Issue , 2010, Pages 1654-1658

  Cafaro, Thamara A ^a   Santo, Stefanía ^a   Robles, Lucena A ^a   Crim, Nicolás ^b   Urrets Zavalia, Julio A ^b   Serra, Horacio M ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b UNIVERSIDAD CATÓLICA DE CÓRDOBA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CITRULLINE; PROTEIN ARGININE DEIMINASE; PROTEIN ARGININE DEIMINASE 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CADAVER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; GLAUCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; OPEN ANGLE GLAUCOMA; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; CITRULLINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLAUCOMA; HUMANS; HYDROLASES; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OPTIC NERVE; TISSUE DONORS;

EID: 77956952310     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Coleman AL. Glaucoma. Lancet 1999; 354:1803-1810.
2. Anderson DR. Collaborative normal tension glaucoma study. Curr Opin Ophthalmol 2003; 14:86-90.
3. Coleman AL. Epidemiology of Glaucoma. In: Morrison JC, Pollack IP, editors. Glaucoma Science and Practice. New York: Thieme Medical Publishers Inc.; 2003. p. 2-11.
4. Morrison JC, Acott TS. Anatomy and physiology of aqueous humor outflow. In: Morrison JC, Pollack IP, editors. Glaucoma Science and Practice. New York: Thieme Medical Publishers Inc.; 2003. p. 34-41.
5. Bhattacharya SK, Crabb JS, Bonilha VL, Gu X, Takahara H, Crabb JW. Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis. Invest Ophthalmol Vis Sci 2006; 47:2508-2514.
6. Watanabe K, Akiyama K, Hikichi K, Ohtsuka R, Okuyama A, Senshu T. Combined biochemical and immunochemical comparison of peptidylarginine deiminases present in various tissues. Biochim Biophys Acta 1988; 966:375-383.
7. Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003; 25:1106-1118.
8. Bhattacharya SK. Retinal deimination in aging and disease. IUBMB Life 2009; 61:504-509.
9. Nicholas AP, Sambandam T, Echols JD, Tourtellotte WW. Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis. J Comp Neurol 2004; 473:128-136.
10. Moscarello MA, Pritzker L, Mastronardi FG, Wood DD. Peptidylarginine deiminase: a candidate factor in demyelinating disease. J Neurochem 2002; 81:335-343.
11. Asaga H, Akiyama K, Ohsawa T, Ishigami A. Increased and type II-specific expression of peptidylarginine deiminase in activated microglia but not hyperplastic astrocytes following kainic acid-evoked neurodegeneration in the rat brain. Neurosci Lett 2002; 326:129-132.